Sunshine Biopharma Inc.
13F holders, Q4 2024 (December 31)12holders +2
3new positions
2sold out
$3.00avg. 13F price*
At the end of Q4 2024, 12 institutions reported holding Sunshine Biopharma Inc. in their 13F filings, up 2 from Q3 2024. 3 opened new positions and 2 sold out. The largest holders were Connective Capital Management, LLC ($34K), Morgan Stanley ($23K) and UBS Group AG ($3K).
- Company
- Sunshine Biopharma Inc.
- CUSIP
- 867781700
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $37K |
| Exits | 2 | $2K |
All 13F filers, Q3 2024 → Q4 2024: 19,857 shares bought and 34,976 shares sold, net −15,119 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Connective Capital Management, LLC | 0.04% | New | 11,345 | $34K |
| Morgan Stanley | 0.00% | Add +763900.0% | 7,640 | $23K |
| UBS Group AG | 0.00% | New | 868 | $3K |
| SBI Securities Co., Ltd. | 0.00% | — | 709 | $2K |
| National Bank of Canada | 0.00% | No change | 7 | $21 |
| Bank of America Corp. | 0.00% | Reduce -100.0% | 5 | $15 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 4 | $12 |
| Osaic Holdings, Inc. | 0.00% | Add +100.0% | 2 | $6 |
| Rise Advisors, LLC | 0.00% | No change | 1 | $3 |
| Farther Finance Advisors, LLC | 0.00% | No change | 1 | $3 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $3 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is SUNSHINE BIOPHARMA INC's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. the manager owns.